Highlights Aequus Pharmaceuticals Inc.

Equities

AQS

CA0076361033

Delayed Toronto S.E. Other stock markets 12:26:39 2024-05-15 EDT			5-day change	1st Jan Change
0.025 ^CAD	0.00%		+66.67%	0.00%

05-10	Aequus Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-30	Aequus Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aequus Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Aequus Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-30	CI
Aequus Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-28	CI
Aequus Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-28	CI
Aequus Pharmaceuticals Inc. Announces Launch of Zimed PF in Canada	23-08-24	CI
Aequus Pharmaceuticals Announces Zimed PF Website Launch	23-08-22	MT
Aequus Pharmaceuticals Inc. Announces Pause in Sales of Evolve Intensive Eyedrop and Intensive Gel Products in Canada	23-08-18	CI
Aequus Pharmaceuticals Announcds Financing to Support Launch of Zimed Preservative Free	23-07-07	MT
Aequus Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-29	CI
Aequus Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-30	CI
Aequus Announces Health Canada Notice of Compliance for Zimed® Preservative Free (Bimatoprost 0.03%)	22-12-20	CI
Aequus Pharmaceuticals Inc. Expects Health Canada Approval for Zimed® PF (Preservative Free)	22-11-29	CI
Aequus Pharmaceuticals Inc. Agrees to End Its Promotional Service Agreement with Sandoz Canada Inc	22-11-29	CI
Aequus Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-28	CI
Aequus Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-29	CI
Aequus Pharmaceuticals Chairman and CEO Doug Janzen Increases Ownership Interest	22-07-25	MT
Aequus Signs Distribution Agreement with SCOPE Ophthalmics for Canadian Distribution Rights of Dry Eye Products	22-07-07	MT
Aequus Pharmaceuticals Inc. Signs Exclusive Distribution Agreement with SCOPE Ophthalmics for Canadian Distribution Rights of Dry Eye Products	22-07-06	CI
Aequus Pharmaceuticals Reports FY 2021, Q1 2022, Financial Results	22-07-04	MT
Aequus Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-06-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Aequus Pharmaceuticals Inc.

Equities

AQS

CA0076361033

Highlights

Filters